Cargando…
Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer
The expression of the tumor suppressor Merlin is compromised in nervous system malignancies due to genomic aberrations. We demonstrated for the first time, that in breast cancer, Merlin protein expression is lost due to proteasome-mediated elimination. Immunohistochemical analysis of tumor tissues f...
Autores principales: | Morrow, K. Adam, Das, Shamik, Meng, Erhong, Menezes, Mitchell E., Bailey, Sarah K., Metge, Brandon J., Buchsbaum, Donald J., Samant, Rajeev S., Shevde, Lalita A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951266/ https://www.ncbi.nlm.nih.gov/pubmed/26908451 http://dx.doi.org/10.18632/oncotarget.7494 |
Ejemplares similares
-
Merlin deficiency alters the redox management program in breast cancer
por: Mota, Mateus, et al.
Publicado: (2021) -
Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling
por: Das, Shamik, et al.
Publicado: (2017) -
Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer
por: Meng, Erhong, et al.
Publicado: (2016) -
Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer
por: Meng, Erhong, et al.
Publicado: (2023) -
The Hedgehog Pathway Conditions the Bone Microenvironment for Osteolytic Metastasis of Breast Cancer
por: Das, Shamik, et al.
Publicado: (2012)